SALIVARY GLAND CANCER

This study tests a drug called zanidatamab in about 200 adults with advanced HER2-positive cancers (like breast, stomach, lung, or ovarian cancer) that have worsened after at least one prior treatment. The goal is to see if the drug can shrink tumors and how long that effect last…

This study looks at how well the drug T-DXd works in adults with advanced HER2-positive cancers that have spread and no longer respond to other treatments. About 100 people will take part, and researchers will track whether tumors shrink and how long the benefit lasts. The goal i…

This study tests whether adding the targeted drug T-DM1 to standard chemoradiation can prevent HER2-positive salivary gland cancer from returning. About 37 adults with advanced but removable tumors will receive the combination and be followed for two years. The goal is to see if …

This early-phase study tests a small implantable device that delivers tiny amounts of different drugs directly into head and neck tumors. The goal is to see which drug works best for each person before full surgery. About 30 adults with certain head and neck cancers will take par…

This study is creating a huge collection of medical information and biological samples from adults with or at risk for many types of cancer, as well as healthy volunteers. The goal is to help researchers better understand cancer causes, improve early detection, and develop person…

This study is building a large registry of people with rare head and neck cancers across Europe. Researchers will collect information from existing databases and doctors to understand how these cancers behave, what affects outcomes, and how well current treatments work. No new tr…